BRIEF published on 06/26/2025 at 10:36, 10 months 9 days ago L'obligation de 750 millions d'euros de CHEPLAPHARM connaît une forte demande et un prix attractif Obligations Confiance Des Investisseurs Médicaments Flexibilité Financière CHEPLAPHARM
PRESS RELEASE published on 06/26/2025 at 10:31, 10 months 9 days ago High Demand and Attractive Pricing: CHEPLAPHARM's New 7.125% Bond Multiple Times Oversubscribed CHEPLAPHARM successfully places €750m senior secured notes at 7.125% interest rate, enhancing financial flexibility and extending maturity profile, oversubscribed transaction Senior Secured Notes Oversubscribed Financial Flexibility CHEPLAPHARM 7.125%
BRIEF published on 06/02/2025 at 10:34, 11 months 3 days ago Sandra Schröder rejoint CHEPLAPHARM en tant que vice-présidente scientifique Pharmaceutique Affaires Réglementaires Gestion De La Qualité CHEPLAPHARM Sandra Schröder
BRIEF published on 06/02/2025 at 10:34, 11 months 3 days ago Sandra Schröder Joins CHEPLAPHARM as VP Scientific Pharmaceutical Regulatory Affairs Quality Management CHEPLAPHARM Sandra Schröder
PRESS RELEASE published on 06/02/2025 at 10:29, 11 months 3 days ago Sandra Schröder joins CHEPLAPHARM’S Management Team as VP Scientific Sandra Schröder appointed as VP Scientific at CHEPLAPHARM, responsible for scientific areas globally. Brings 25 years of experience from F. Hoffmann-La Roche AG Pharmaceutical Industry Management CHEPLAPHARM Sandra Schröder VP Scientific
BRIEF published on 01/02/2025 at 09:19, 1 year 4 months ago CHEPLAPHARM Appoints Tamás Szóga as VP Commercial Management Expansion CHEPLAPHARM Tamás Szóga VP Commercial Pharmaceutical Strategy
BRIEF published on 01/02/2025 at 09:19, 1 year 4 months ago CHEPLAPHARM nomme Tamás Szóga au poste de vice-président commercial Expansion De La Gestion CHEPLAPHARM Tamás Szóga Vice-président Commercial Stratégie Pharmaceutique
PRESS RELEASE published on 01/02/2025 at 09:14, 1 year 4 months ago CHEPLAPHARM expands Management with Tamás Szóga as VP Commercial CHEPLAPHARM expands management team by appointing Tamás Szóga as VP Commercial, responsible for strategic planning and development of Global Sales division Global Sales Strategic Planning CHEPLAPHARM Tamás Szóga VP Commercial
BRIEF published on 12/16/2024 at 08:53, 1 year 4 months ago CHEPLAPHARM Acquires Gemzar from Lilly Acquisition Oncology Eli Lilly CHEPLAPHARM Gemzar
BRIEF published on 12/16/2024 at 08:53, 1 year 4 months ago CHEPLAPHARM acquiert Gemzar auprès de Lilly Acquisition Oncologie Eli Lilly CHEPLAPHARM Gemzar
Published on 05/06/2026 at 00:20, 39 minutes ago Hillcrest Energy Technologies Announces Adoption of Semi-Annual Reporting
Published on 05/06/2026 at 00:00, 59 minutes ago Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation
Published on 05/05/2026 at 23:00, 1 hour 59 minutes ago Viemed Healthcare Announces First Quarter 2026 Financial Results
Published on 05/05/2026 at 23:00, 1 hour 59 minutes ago Grid Metals Announces TSX Venture Approval for Thompson East Copper/Nickel Project Earn-In Transaction
Published on 05/05/2026 at 22:30, 2 hours 29 minutes ago Totec Resources Adopts Semi-Annual Reporting
Published on 05/06/2026 at 00:05, 54 minutes ago ESOC 2026: Rising stroke rates highlight widening ethnic and socioeconomic inequalities across populations, major study finds
Published on 05/05/2026 at 23:05, 1 hour 54 minutes ago Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
Published on 05/05/2026 at 22:07, 2 hours 52 minutes ago Kaufman & Broad SA: MISE EN PAIEMENT DU DIVIDENDE AU TITRE DE L’EXERCICE CLOS LE 30 NOVEMBRE 2025
Published on 05/05/2026 at 22:07, 2 hours 52 minutes ago Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2025
Published on 05/05/2026 at 21:56, 3 hours 2 minutes ago Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM OF 2026, MAY 5
Published on 05/05/2026 at 19:00, 5 hours 59 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 19:00, 5 hours 59 minutes ago Assemblée Générale Mixte des Actionnaires d’Air Liquide du 5 mai 2026
Published on 05/05/2026 at 18:40, 6 hours 19 minutes ago Mise en œuvre du programme de rachat d’actions
Published on 05/05/2026 at 18:03, 6 hours 56 minutes ago Aéroports de Paris SA - Actions et droits de vote au 30 avril 2026
